Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.

Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.

Regarding the Importance of experience sharing about Lung cancer patients with COVID-19 complications, a multidisciplinary virtual Meeting was held on December 3rd 2020 …

“Updates On Colorectal Cancer”, a cooperative event by Iranian Society of Radiation Oncology (ISRO) & Actero

Considering the current situation in the country and taking into account the needs of patients, Actero Company decided to spend all the costs related to the unveiling of the drug Bortezomib ACTe on the first free injection of patients’ candidates receiving Bortezomib.

Simultaneously with the unveiling of Onkotaxel (Docetaxel of Actero Company), a subspecialized webinar was held on July 23rd with the presence of Dr. Safa Najafi (Medical Oncologist), Dr. Samiei (Radiotherapy Oncologist), Dr. Azimi Nejadan (Surgeon) and Ms. Dr. Ehsani (Pathologist) on August 2.

After opening and operating the injection drug production line last year and increasing its production capacity in order to expand the product basket portfolio in the New Year, Actero factory, which specializes in the production of cancer drugs, intends to meet the needs of cancer patients in most treatment protocols.

With continuous monitoring of international research and protocols, it was suggested to produce drugs in the treatment of Covid-19 in the Actover group, as a pioneer in the production of drugs needed in Covid 19, the group unveiled two drugs, Remdesivir and Favipiravir.

The presence of Actover Pharmaceutical Group in the second Pharmex exhibition on June 30th to July 2nd at the Olympic Hotel as the main sponsor.

Actero Company, considering its social responsibility and in order to meet the needs of Covid 19 disease aids, immediately imported the desired items and to some extent met the needs of the dear patients of the country.

Holding a subspecialty webinar on multiple myeloma management and COVID-19 on May 21st